Journal of Applied Spectroscopy

, Volume 82, Issue 3, pp 502–512 | Cite as

New Spectrophotometric Assay of Pyrantel Pamoate in Pharmaceuticals and Spiked Human Urine Using Three Complexing Agents

  • N. Swamy
  • K. N. Prashanth
  • K. Basavaiah

Three simple, rapid, inexpensive, and highly sensitive spectrophotometric methods are described for the quantifi cation of pyrantel pamoate (PYP) in pure drug and formulations. The methods are based on the molecular charge-transfer (CT) complexation reaction involving pyrantel base (PYL) as n-donor and iodine as σ-acceptor (I 2 , method A), and 2,4-dinitrophenol (DNP, method B) or picric acid (PA, method C) as π-acceptors. Spectrophotometrically, the CT complexes showed absorption maxima at 380, 420, and 430 nm, for methods A, B, and C, respectively. Under optimum conditions, Beer's law was obeyed over the concentration ranges 0.12–2.9, 0.12–3.75, and 0.12–2.9 μg/ml for methods A, B, and C, respectively. The apparent molar absorptivity of the CT complexes at the respective λmax are calculated to be 2.63 × 10 5 , 6.91 × 10 4 , and 1.73 × 10 5 l/mol·cm respectively and the corresponding Sandell sensitivity values are 0.0009, 0.003, and 0.0012. The limits of detection (LOD) and quantification (LOQ) are calculated to be (0.02 and 0.07), (0.05 and 0.15), and (0.02 and 0.07) μg/ml with methods A, B, and C, respectively. The intra-day and inter-day accuracy expressed as %RE and precision expressed as %RSD are less than 3%. The methods have been applied to the determination of PYP in tablets, suspensions, and spiked human urine. Parallel assay by a reference method and statistical analysis of the results obtained show no significant difference between the proposed methods and the reference method with respect to accuracy and precision, as evident from the Student’s t and variation ratio tests. The accuracy of the methods has been further ascertained by recovery tests via the standard addition technique.


pyrantel pamoate assay spectrophotometry pharmaceuticals charge-transfer complexation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. L. Olivares, R. Fernandez, J. Heta, G. Rodrignez, and A. Clavel, Dig. Dis., 21, 258–261 (2003).CrossRefGoogle Scholar
  2. 2.
    H. Bjorn, D. R. Hennessy, and C. Fris, Int. J. Parasitol., 26, 1375–1380 (1996).CrossRefGoogle Scholar
  3. 3.
    V. Hadju, L. S. Stepenson, K. Abadi, H. O. Mohammed, D. D. Bowmann, and R. S. Parker, Parasitol., 113, 497–504 (1996).CrossRefGoogle Scholar
  4. 4.
    H. J. Rim and J. K. Lim, Trans. Roy. Soc. Trop. Med. Hyg., 66, 170–175 (1972).CrossRefGoogle Scholar
  5. 5.
    H. J. Rim and J. K. Lim, Asian. J. Med., 9, 393–399 (1973).Google Scholar
  6. 6.
    The United States Pharmacopoeia, The National Formularly, USP 24. NF 19, USP Convention Inc. 12601, Twinbrook Parkway, Rockville, MD (2005) 1678.Google Scholar
  7. 7.
    E. G. Oltean, Med. Vet/Vet. Drug., 5, 64–67 (2011).Google Scholar
  8. 8.
    W. J. Allender, Oxford J., 26, 470–472 (1988).Google Scholar
  9. 9.
    H. Lucie, B. Ivana, S. Dalibor, M. Ludmila, L. Alena, O. Zdenek, and S. Petr, Anal. Methods, 4, 1592–1597 (2012).CrossRefGoogle Scholar
  10. 10.
    G. Zhiyuan, X. Yan, and H. Ying, Lei Huaxi Yaoxue Zazhi, 19, 462–463 (2004).Google Scholar
  11. 11.
    R. Raman and V. M. Shinde, Indian Drugs, 36, 167–172 (1999).Google Scholar
  12. 12.
    A. P. Argekar, S. V. Raj, and S. U. Kapadia, Talanta, 44, 1959–1965 (1997).CrossRefGoogle Scholar
  13. 13.
    U. P. Halkar, S. H. Rane, and N. P. Bhandari, Indian Drugs, 34, 194–196 (1997).Google Scholar
  14. 14.
    W. J. Allender, J. Chromatogr. Sci., 26, 470–472 (1988).CrossRefGoogle Scholar
  15. 15.
    A. J. Konrardy, A. M. Burner, T. W. Garner, A. M. Litchman, and K. G. Webster, J. AOAC Int., 86, 882–887 (2003).Google Scholar
  16. 16.
    Anon, Indian Drugs, 35, 49–51 (1998).Google Scholar
  17. 17.
    S. S. Zarapkar, S. S. Kolte, and S. H. Rane, Indian Drugs, 34, 707–709 (1997).Google Scholar
  18. 18.
    A. F. George, F. M. Robert, and L. W. Richard, J. Pharm. Sci., 60, 111–113 (1971).CrossRefGoogle Scholar
  19. 19.
    A. S. Langade, R. M. Charde, M. S. Charde, and M. R. Tajne, J. Pharm. Sci., 3, 212–215 (2010).Google Scholar
  20. 20.
    P. B. N. Prasad, A. C. S. Rao, S. C. Mathur, Y. Kumar, and S. K. Talwar, Indian Drugs, 36, 403–407 (1999).Google Scholar
  21. 21.
    G. Hancu and A. Gyeresi, Farmacia (Bucharest), 47, 11–19 (1999).Google Scholar
  22. 22.
    I. H. Refaat, M. E. El-Kommos, H. H. Farag, and N. A. El-Rabat, Bull. Pharm. Sci., 10, 85–102 (1987).Google Scholar
  23. 23.
    J. Rajeev, J. Nimisha, and K. Radhapyari, Talanta, 70, 383–386 (2006).CrossRefGoogle Scholar
  24. 24.
    V. K. Gupta, R. Jain, N. Jadon, and K. Radhapyari, J. Coll. Int. Sci., 350, 330–335 (2010).CrossRefGoogle Scholar
  25. 25.
    D. C. Tiwari, R. Jain, and G. Sahu, J. Ind. Chem. Soc., 10, 1047–1050 (2009).Google Scholar
  26. 26.
    R. Aubeck and N. Hampp, Anal. Chim. Acta, 256, 257–262 (1992).CrossRefGoogle Scholar
  27. 27.
    K. Basavaiah and H. C. Prameela, Chem. Anal. (Warsaw), 48, 327–334 (2003).Google Scholar
  28. 28.
    C. S. R. Lakshmi and M. N. Reddy, Ind. J. Pharm. Sci., 60, 302–304 (1998).Google Scholar
  29. 29.
    D. M. Shingbal and V. R. Rao, Indian Drugs, 25, 22–24 (1987).Google Scholar
  30. 30.
    C. S. R. Lakshmi and M. N. Reddy, East. Pharm., 41, 127–128 (1998).Google Scholar
  31. 31.
    O. O. Johnson and U. Ajima, Int. Drug Dev. Res., 3, 199–204 (2011).Google Scholar
  32. 32.
    K. N. Prashanth and K. Basavaiah, Acta Pol. Pharm. Drug Res., 69, 213–223 (2012).Google Scholar
  33. 33.
    T. Karuna, K. Neelima, G. Venkateshwarulu, and P. Yadagiriswamy, J. Sci. Ind. Res., 65, 808–811 (2006).Google Scholar
  34. 34.
    S. A. M. Abdulrahman and K. Basavaiah, Int. J. Anal. Chem., 1–9 (2011) ID 619310.Google Scholar
  35. 35.
    International Conference on Hormonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R 1), Complementary Guideline on Methodology, 6 November 1996, London (2005).Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Chemistry, ManasagangothriUniversity of MysoreKarnatakaIndia

Personalised recommendations